Point-of-care biomarkers in asthma management: time to move forward

Kjell Alving (Corresponding Author), Zuzana Diamant, Sarah Lucas, Helgo Magnussen, Ian D Pavord, Giorgio Piancentini, David Price, Nicolas Roche, Joaquin Sastre, Mike Thomas, Omar Usmani, Leif Bjermer, Respiratory Effectiveness Group, Biomarkers Working Group

Research output: Contribution to journalArticle

Abstract

The Global Initiative for Asthma (GINA) report was primarily intended as a strategy document and not a clinical guideline. However, the 2014 update moved the report towards a "practical, clinical practice‐centred document", and has in many countries formed a basis for national guidelines. A possible limitation of the GINA report is its primary focus on evidence coming from randomised controlled trials, potentially leading to the omission of clinically important data coming from real‐life and observational studies, and in conclusions based on highly‐selected asthmatic patients, fulfilling strict study inclusion criteria.
Original languageEnglish
Pages (from-to)995-997
Number of pages3
JournalAllergy
Volume75
Issue number4
Early online date7 Oct 2019
DOIs
Publication statusPublished - Apr 2020

Keywords

  • EXHALED NITRIC-OXIDE
  • PREDICTOR

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Fingerprint Dive into the research topics of 'Point-of-care biomarkers in asthma management: time to move forward'. Together they form a unique fingerprint.

  • Cite this

    Alving, K., Diamant, Z., Lucas, S., Magnussen, H., Pavord, I. D., Piancentini, G., Price, D., Roche, N., Sastre, J., Thomas, M., Usmani, O., Bjermer, L., & Respiratory Effectiveness Group, Biomarkers Working Group (2020). Point-of-care biomarkers in asthma management: time to move forward. Allergy, 75(4), 995-997. https://doi.org/10.1111/all.14045